Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 4

Results: 24

Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 815, doi. 10.1038/sj.leu.2402830

By:

Bock, Oliver;
Schlue, Jerome;
Kreipe, Hans

Publication type:

Article

Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia1.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 716, doi. 10.1038/sj.leu.2402835

By:

Panoskaltsis, N;
Reid, C D L;
Knight, S C

Publication type:

Article

MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 813, doi. 10.1038/sj.leu.2402841

By:

Paulsson, K;
Lassen, C;
Kuric, N;
Billstrom, R;
Fioretos, T;
Tanke, H J;
Johansson, B

Publication type:

Article

Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 816, doi. 10.1038/sj.leu.2402853

By:

Calado, R T;
Machado, C G;
Carneiro, J J;
Garcia, A B;
Falcao, R P

Publication type:

Article

Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 746

By:

Campas, C;
Dalmau, M;
Montaner, B;
Barragan, M;
Bellosillo, B;
Colomer, D;
Pons, G;
Perez-Tomas, R;
Gil, J

Publication type:

Article

FGF-2 expression and its action in human leukemia and lymphoma cell lines.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 818, doi. 10.1038/sj.leu.2402861

By:

Krejci, P;
Faitova, J;
Laurell, H;
Hampl, A;
Dvorak, P

Publication type:

Article

HLA-DR antigen-negative acute myeloid leukemia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 707, doi. 10.1038/sj.leu.2402865

By:

Wetzler, M;
McElwain, B K;
Stewart, C C;
Blumenson, L;
Mortazavi, A;
Ford, L A;
Slack, J L;
Barcos, M;
Ferrone, S;
Baer, M R

Publication type:

Article

Thalidomide as initial therapy for early-stage myeloma.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 775, doi. 10.1038/sj.leu.2402866

By:

Rajkumar, S V;
Gertz, M A;
Lacy, M Q;
Dispenzieri, A;
Fonseca, R;
Geyer, S M;
Iturria, N;
Kumar, S;
Lust, J A;
Kyle, R A;
Greipp, P R;
Witzig, T E

Publication type:

Article

Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 811, doi. 10.1038/sj.leu.2402867

By:

Chabannon, C;
Le Corroller, A-G;
Viret, F;
Eillen, C;
Faucher, C;
Moatti, J-P;
Viens, P;
Vey, N;
Braud, A-C;
Novakovitch, G;
Ladaique, P;
Stoppa, A-M;
Camerlo, J;
Genre, D;
Maraninchi, D;
Blaise, D

Publication type:

Article

Intramuscular edema as a complication of treatment with imatinib.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 804, doi. 10.1038/sj.leu.2402868

By:

Shimazaki, C;
Ochiai, N;
Uchida, R;
Fuchida, S-I;
Okano, A;
Ashihara, E;
Inaba, T;
Fujita, N;
Nakagawa, M

Publication type:

Article

G-CSF for Imatinib-induced neutropenia.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 805, doi. 10.1038/sj.leu.2402869

By:

Heim, D;
Ebnother, M;
Meyer-Monard, S;
Tsakiris, D;
Linn, M;
Tichelli, A;
Gratwohl, A

Publication type:

Article

Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL1.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 691, doi. 10.1038/sj.leu.2402879

By:

Schiffer, C A;
Hehlmann, R;
Larson, R

Publication type:

Article

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 796, doi. 10.1038/sj.leu.2402881

By:

Levy, R

Publication type:

Article

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 760, doi. 10.1038/sj.leu.2402882

By:

Feuring-Buske, M;
Gerhard, B;
Cashman, J;
Humphries, R K;
Eaves, C J;
Hogge, D E

Publication type:

Article

Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 731, doi. 10.1038/sj.leu.2402871

By:

Nishii, K;
Usui, E;
Katayama, N;
Lorenzo V, F;
Nakase, K;
Kobayashi, T;
Miwa, H;
Mizutani, M;
Tanaka, I;
Nasu, K;
Dohy, H;
Kyo, T;
Taniwaki, M;
Ueda, T;
Kita, K;
Shiku, H

Publication type:

Article

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment.

Published in:

2003

By:

Royer-Pokora, B;
Hildebrandt, B;
Redmann, A;
Herold, C;
Kronenwett, R;
Haas, R;
Drechsler, M;
Wieland, C

Publication type:

Case Study

Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 751, doi. 10.1038/sj.leu.2402870

By:

Moisan, S;
Demers, M;
Mercier, J;
Magnaldo, T;
Potworowski, E F;
St-Pierre, Y

Publication type:

Article

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 789, doi. 10.1038/sj.leu.2402880

By:

Lossos, I S;
Czerwinski, D K;
Wechser, M A;
Levy, R

Publication type:

Article

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

Published in:

2003

By:

Gadner, H;
Haas, O A;
Masera, G;
Pui, C-H;
Schrappe, M;
'Ponte di Legno' Working Group

Publication type:

research

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

Published in:

2003

By:

Derksen, P W B;
de Gorter, D J J;
Meijer, H P;
Bende, R J;
van Dijk, M;
Lokhorst, H M;
Bloem, A C;
Spaargaren, M;
Pals, S T

Publication type:

journal article

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 700, doi. 10.1038/sj.leu.2402883

By:

Pui, C.-H.;
Chessells, J. M.;
Camitta, B.;
Baruchel, A.;
Biondi, A.;
Boyett, J. M.;
Carroll, A.;
Eden, O. B.;
Evans, W. E.;
Gadner, H.;
Harbott, J.;
Harms, D. O.;
Harrison, C. J.;
Harrison, P. L.;
Heerema, N.;
Janka-Schaub, G.;
Kamps, W.;
Masera, G.;
Pullen, J.;
Raimondi, S. C.

Publication type:

Article

Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 738, doi. 10.1038/sj.leu.2402884

By:

Gesk, S;
Martin-Subero, J I;
Harder, L;
Luhmann, B;
Schlegelberger, B;
Calasanz, M J;
Grote, W;
Siebert, R

Publication type:

Article

A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia1.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 780, doi. 10.1038/sj.leu.2402885

By:

van Stijn, A;
Kok, A;
van der Pol, M A;
Feller, N;
Roemen, G M J M;
Westra, A H;
Ossenkoppele, G J;
Schuurhuis, G J

Publication type:

Article

Multiparameter flow cytometric quantification of apoptosis-related protein expression.

Published in:

Leukemia (08876924), 2003, v. 17, n. 4, p. 787, doi. 10.1038/sj.leu.2402886

By:

van Stijn, A;
Kok, A;
van der Pol, M A;
Feller, N;
Roemen, G M J M;
Westra, A H;
Ossenkoppele, G J;
Schuurhuis, G J

Publication type:

Article

Works matching IS 08876924 AND DT 2003 AND VI 17 AND IP 4

Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.

Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia<sup>1</sup>.

MYC is not overexpressed in a case of chronic myelomonocytic leukemia with MYC-containing double minutes.

Age-related changes of P-glycoprotein-mediated rhodamine 123 efflux in normal human bone marrow hematopoietic stem cells.

Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia.

FGF-2 expression and its action in human leukemia and lymphoma cell lines.

HLA-DR antigen-negative acute myeloid leukemia.

Thalidomide as initial therapy for early-stage myeloma.

Cost-effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation.

Intramuscular edema as a complication of treatment with imatinib.

G-CSF for Imatinib-induced neutropenia.

Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL<sup>1</sup>.

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.

Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.

Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment.

Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype.

Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies.

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci.

A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia<sup>1</sup>.

Multiparameter flow cytometric quantification of apoptosis-related protein expression.